Orion Corporation Publishes Financial and Remuneration Reports for 2024
Orion Corporation, a leading Finnish pharmaceutical company, has recently made public its Financial Statement documents for the year 2024. Notably, these important documents are detailed and available in both Finnish and English on the Company’s website. They provide insight into Orion’s financial performance and governance strategies.
Content of the Financial Statement Documents
The Financial Statement documents encompass the Financial Statements, the Report by the Board of Directors, along with the Sustainability Statement and Corporate Governance Statement, which are included as part of the Board's report. These components aim to provide a comprehensive overview of the company’s operations and financial health.
Compliance with Reporting Standards
In alignment with the European Single Electronic Format (ESEF) reporting mandates, the Financial Statements have been articulated in an xHTML format. Furthermore, significant components of the Consolidated financial statements are tagged with XBRL to ensure precision and clarity in financial reporting. Notably, KPMG Oy Ab has contributed an independent auditor’s report that offers their reasonable assurance on the accuracy of the ESEF Financial Statements.
Sustainability and Governance
The Sustainability Statement stands out as it adheres to the standards set forth by the European Sustainability Reporting Standards (ESRS) and the Finnish Accounting Act regarding sustainability reporting. For added credibility, KPMG Oy Ab has also assured this report to a limited assurance level under ISAE 3000 (revised), highlighting Orion’s commitment to sustainability.
Detailed Documents Available for Stakeholders
All relevant Financial Statement documents, which meet Finnish Accounting Act and Companies Act requirements, are accessible in Finnish. This collection includes not only Financial Statements but also the Board’s Report, Sustainability Statement, Corporate Governance Statement, and both the Auditor’s Report and the Assurance Report on the Sustainability Report. Stakeholders can find this comprehensive information on the Company’s official platforms.
Overview of the Remuneration Report 2024
Additionally, Orion has released a separate Remuneration Report for 2024, detailing the company's policies regarding compensation for its executives and board members. This report, also available in Finnish and English, is aligned with transparency principles and underscores the company’s commitment to fair and responsible remuneration practices.
Operational Highlights and Market Position
As a pharmaceutical pioneer with over a century of experience, Orion develops, manufactures, and markets a wide array of human and veterinary pharmaceuticals as well as active pharmaceutical ingredients. The company boasts a diverse portfolio that includes both proprietary and generic medicines, alongside consumer health products that are firmly rooted in oncology and pain management.
Through state-of-the-art research and development, proprietary products from Orion are instrumental in treating various conditions, including cancer and neurological disorders. In 2024, Orion reported net sales reaching EUR 1,542 million, solidifying its robust market position and reflecting its ongoing growth. The workforce comprises approximately 3,700 employees, all dedicated to the vision of advancing health and well-being.
Contact and Further Information
For any inquiries or additional information regarding the Financial Statement documents or the Remuneration Report, individuals may reach out to:
Contact Person:
Tuukka Hirvonen, Investor Relations
Telephone: +358 10 426 2721
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Website: www.orionpharma.com
Frequently Asked Questions
What are the main highlights of Orion's 2024 Financial Statements?
The 2024 Financial Statements reveal Orion's net sales of EUR 1,542 million and showcase their commitment to sustainability and governance.
Who audited Orion's Financial Statements for 2024?
KPMG Oy Ab provided independent assurance on Orion's Financial Statements following the ESEF reporting requirements.
Where can I find the Sustainability Statement?
The Sustainability Statement is included in the Financial Statement documents and is available on the Company’s website along with other reports.
What is included in the Remuneration Report?
The Remuneration Report outlines Orion's compensation policies for executives and board members and emphasizes transparency in their remuneration strategies.
How does Orion contribute to healthcare?
Orion develops a broad range of pharmaceuticals and active ingredients, significantly impacting treatment areas such as oncology and pain management.
